In patients with leprosy, lepromin test is performed after injecting intradermally 0.1 ml of lepromin. This test is used for:
The lepromin test is a skin test used in leprosy. I remember that it's similar to the tuberculin test. The test involves injecting lepromin intradermally and checking for a delayed-type hypersensitivity reaction. The purpose of the test is to determine the cell-mediated immunity to Mycobacterium leprae. So the correct answer is probably related to immune response or classification of leprosy.
Common options for such a question might include things like diagnosing leprosy, determining prognosis, assessing cell-mediated immunity, or differentiating between leprosy types. Since the lepromin test isn't used for initial diagnosis because of false negatives in early stages, the correct answer is likely about immune status or classification.
The lepromin test is more useful in understanding the immune response and classifying the type of leprosy (tuberculoid vs. lepromatous). A positive test (induration) indicates a strong cell-mediated immunity, which is associated with tuberculoid leprosy. A negative result suggests a weak immune response, seen in lepromatous leprosy. So the test helps in classification rather than diagnosis.
Now, the wrong options would be things like diagnosing leprosy (incorrect because it's not used for initial diagnosis), determining drug resistance (which isn't related), or monitoring treatment response (also not directly).
The clinical pearl here is that the lepromin test isn't for diagnosis but for understanding the immune status and classifying the disease. Students might confuse it with the tuberculin test but need to remember the specific use in leprosy.
**Core Concept**
The lepromin test assesses cell-mediated immunity to *Mycobacterium leprae*, aiding in classifying leprosy into tuberculoid (TT) or lepromatous (LL) types. It is not used for diagnosis but to evaluate immune status and disease progression.
**Why the Correct Answer is Right**
The lepromin test induces a delayed-type hypersensitivity reaction (induration >5 mm at 7–14 days) in patients with strong cell-mediated immunity (e.g., tuberculoid leprosy). A negative test indicates impaired immunity (e.g., lepromatous leprosy). This reflects the Th1/Th2 immune balance, with Th1 dominance in TT and Th2 in LL.
**Why Each Wrong Option is Incorrect**
**Option A:** *Diagnosing active leprosy* – Incorrect. The test is not diagnostic; it’s false-negative in early leprosy due to anergy.
**Option B:** *Determining drug resistance* – Incorrect. Drug resistance is assessed via bacterial culture or molecular testing, not immune testing.
**Option D:** *Monitoring treatment efficacy* – Incorrect. Clinical and bacteriological responses are used, not lepromin reactivity.
**Clinical Pearl / High-Yield Fact**
Never use the lepromin test for initial leprosy diagnosis. It is most useful for classifying leprosy into immun